Requirement of peptidergic sensory innervation for disease activity in murine models of immune hepatitis and protection by β-adrenergic stimulation

Journal of Neuroimmunology

Volumn 96, Issue 2, 1999, Pages 131-143

  Tiegs, Gisa ^a   Bang, Renate ^a   Neuhuber, Winfried L ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Con A hepatitis; D galactosamine; Liver; Superantigen; T lymphocytes; Tumor necrosis factor

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CAPSAICIN; CONCANAVALIN A; GALACTOSAMINE; OXIDOPAMINE; SALBUTAMOL; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; CHEMICAL SYMPATHECTOMY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; HEPATITIS; MALE; MOUSE; NONHUMAN; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; SENSORY NERVE;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANIMALS; CAPSAICIN; CATECHOLAMINES; HEPATITIS, ANIMAL; IMMUNE SYSTEM DISEASES; LIVER; MALE; MICE; MICE, INBRED BALB C; NERVE FIBERS; NEURONS, AFFERENT; RECEPTORS, ADRENERGIC, BETA; SYMPATHECTOMY, CHEMICAL;

EID: 0033519199     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00014-4     Document Type: Article

References (95)

1. Arvidsson U., Riedl M., Elde R., Meister B. Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J. Comp. Neurol. 378:1997;454-467.
2. Baron R., Jänig W. Sympathetic and afferent neurons projection in the splenic nerve of the cat. Neurosci. Lett. 94:1988;109-113.
3. Benbernou N., Esnault S., Shin H.C., Fekkar H., Guenounou M. Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology. 91:1997;361-368.
4. Bette M., Schäfer M.K.-H., van Rooijen N., Weihe E., Fleischer B. Distribution and kinetics of superantigen-induced cytokine gene expression in mouse spleen. J. Exp. Med. 178:1993;1531-1540.
5. Blum A.M., Metwali A., Cook G., Mathew R.C., Elliott D., Weinstock J.V. Substance P modulates antigen-induced, IFNγ production in murine Schistosomiasis mansoni. J. Immunol. 151:1993;225-233.
6. Bozic C.R., Lu B., Höpken U.E., Gerard C., Gerard N.P. Neurogenic amplification of immune complex inflammation. Science. 273:1996;1722-1725.
7. Calvo C.F., Chavanel G., Senik A. Substance P enhances IL-2 expression in activated human T cells. J. Immunol. 148:1992;3498-3504.
8. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 389:1997;816-824.
9. Chelmicka-Schorr E., Kwasniewski M.N., Wollmann R.L. Sympathectomy augments adoptively transferred experimental allergic encephalomyelitis. J. Neuroimmunol. 37:1992;99-103.
10. Dickerson C., Undem B., Bullock B., Winchurch R.A. Neuropeptide regulation of proinflammatory cytokine responses. J. Leukoc. Biol. 63:1998;602-605.
11. Dienes H.P., Hüttenroth T., Hess G., Meuer S. Immunoelectron observation on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B. Hepatology. 7:1987;1317-1325.
12. Ding M., Hart R.P., Jonakait G.M. Tumor necrosis factor-α induces substance P in sympathetic ganglia through sequential induction of interleukin-1 and leukemia inhibitory factor. J. Neurobiol. 28:1995;445-454.
13. Dopp J.M., Mackenzie-Graham A., Otero G.C., Merrill J.E. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J. Neuroimmunol. 75:1997;104-112.
14. Elenkov I.J., Hasko G., Kovacs K.J., Vizi E.S. Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α- and β-adrenergic drugs in mice. J. Neuroimmunol. 61:1995;123-131.
15. Elmquist J.K., Scammell T.E., Saper C.B. Mechanisms of CNS response to systemic immune challenge: the febrile response. Trends Neurosci. 20:1997;565-570.
16. Ericsson A., Liu C., Hart R.P., Sawchenko P.E. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J. Comp. Neurol. 361:1995;681-698.
17. Feldman R.D., Hunninghake G.W., McArdle W. β-adrenergic receptor-mediated suppression of interleukin-2 receptors in human lymphocytes. J. Immunol. 139:1987;3355-3359.
18. Felten D.L., Felten S.Y., Carlson S.L., Olschowka J.A., Livna S. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 135:1985;755s-765s.
19. Felten D.L., Felten S.Y., Bellinger D.L., Carlson S.L., Ackerman K.D., Madden K.S., Olschowski J.A., Livnat S. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol. Rev. 100:1987;225-260.
20. Feng Y., Tang Y., Gou J., Wang X. Inhibition of LPS-induced TNFα production by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages. Life Sci. 61:1997;PL281-287.
21. Fink T., Weihe E. Multiple neuropeptides in nerves supplying mammalian lymph nodes: messenger candidates for sensory and autonomic neuroimmunomodulation? Neurosci. Lett. 90:1988;39-44.
22. Gantner F., Leist M., Jilg S., Germann P.G., Freudenberg M.A., Tiegs G. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology. 109:1995;166-176.
23. Gantner F., Leist M., Lohse A.W., Germann P.G., Tiegs G. Concanavalin A-induced T cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology. 21:1995;190-198.
24. Gantner F., Leist M., Küsters S., Vogt K., Volk H.D., Tiegs G. T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release. Exp. Cell Res. 229:1996;137-146.
25. Gantner F., Küsters S., Wendel A., Hatzelmann A., Schudt C., Tiegs G. Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors. J. Pharmacol. Exp. Ther. 280:1997;53-60.
26. Goetzl E.J., Adelman D.C., Sreedharan S.P. Neuroimmunology. Adv. Immunol. 48:1990;161-190.
27. Hartung H.P., Wolters K., Toyka K.V. Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J. Immunol. 136:1986;3856-3863.
28. Heym, C., 1981. Fluorescence histochemistry of biogenic monoamines. In: Heym, C., Forssmann, W.G. (Eds.), Techniques in Neuroanatomical Research, Springer, Berlin, pp. 139-170.
29. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinines, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 24:1988;739-768.
30. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev. 43:1991;143-201.
31. Holzer P. Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev. Physiol. Biochem. Pharmacol. 121:1992;49-146.
32. Hopkins S.J., Rothwell N.J. Cytokines and the nervous system: I. expression and recognition. Trends Neurosci. 18:1995;83-88.
33. Horder, M., Rej, R., 1984. Alanine-aminotransferase. In: Bergmeyer, H.U. (Ed.), Methods of Enzymatic Analysis, 3rd edn., Verlag Chemie, Weinheim, Germany, pp. 444-456.
34. Hua X.Y., Chen P., Fox A., Myers R.R. Involvement of cytokines in lipopolysaccharide-induced facilitation of CGRP release from capsaicin-sensitive nerves in the trachea: studies with interleukin-1β and tumor necrosis factor-α J. Neurosci. 16:1996;4742-4748.
35. Ignatowski T.A., Spengler R.N. Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity. J. Neuroimmunol. 61:1995;61-70.
36. Jancso G., Kiraly E., Jancso-Gabor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurons. Nature. 270:1977;741-743.
37. Jonsson, G., 1981. Lesion methods in neurobiology. In: Heym, C., Forssmann, W.G. (Eds.), Techniques in Neuroanatomical Research, Springer, Berlin, pp. 71-99.
38. Kaltreider H.B., Ichikawa S., Byrd P.K., Ingram D.A., Kishiyama J.L., Sreedharan S.P., Warnock M.L., Beck J.M., Goetzl E.J. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am. J. Respir. Cell Mol. Biol. 16:1997;133-144.
39. Kawatani M., Lowe I.P., Nadelhaft I., Morgan C., De Groat W.C. Vasoactive intestinal polypeptide in visceral afferent pathways to the sacral spinal cord of the cat. Neurosci. Lett. 42:1983;311-316.
40. Klinkert W.E., Kojima K., Lesslauer W., Rinner W., Lassmann H., Weckerle H. TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview. J. Neuroimmunol. 72:1997;163-168.
41. 2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263:1988;5380-5384.
42. Küsters S., Gantner F., Künstle G., Tiegs G. Interferon-γ plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology. 111:1996;462-471.
43. Küsters S., Tiegs G., Alexopoulou L., Pasparakis M., Douni E., Künstle G., Blüthmann H., Wendel A., Pfizenmaier K., Kollias G., Grell M. In vivo evidence for a functional role of both TNF receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 27:1997;2870-2875.
44. Lee H.R., Ho W.Z., Douglas S.D. Substance P augments tumor necrosis factor release in human monocyte-derived macrophages. Clin. Diagn. Lab. Immunol. 1:1994;419-423.
45. Leist M., Gantner F., Bohlinger I., Tiegs G., Germann P.G., Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 146:1995;1220-1234.
46. Leonard J.P., MacKenzie F.J., Patel H.A., Cuzner M.L. Splenic noradrenergic and adrenocortical responses during the preclinical and clinical stages of adoptively transferred experimental autoimmune encephalomyelitis (EAE). J. Neuroimmunol. 26:1990;183-186.
47. Levine J.D., Dardick S.J., Roizen M.F., Helms C., Basbaum A.I. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J. Neurosci. 6:1986;3423-3429.
48. Lin Y.S., Nosaka S., Amakata Y., Maeda T. Comparative study of the mammalian liver innervation: an immunohistochemical study of protein gene product 9.5, dopamine beta-hydroxylase and tyrosine hydroxylase. Comp. Biochem. Physiol. A Physiol. 110:1995;289-298.
49. Lotz M., Vaughan J.H., Carson D.A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science. 241:1988;1218-1221.
50. Loveland B.E., Jarrott B., McKenzie I.F.C. The detection of β-adrenoreceptors on murine lymphocytes. Int. J. Immunopharmacol. 3:1981;45-55.
51. Lundberg L.M., Alm P., Wharton J., Polak J.M. Protein gene product 9.5 (PGP 9.5): a new neuronal marker visualizing the whole uterine innervation and pregnancy-induced and developmental changes in the guinea pig. Histochemistry. 90:1988;9-17.
52. Madden K.S., Moynihan J.A., Brenner G.J., Felten S.Y., Felten D.L., Livnat S. Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. J. Neuroimmunol. 49:1994;77-87.
53. Markus A.M.A., Köckerling F., Neuhuber W.L. Close anatomical relationship between nerve fibres and MHC class II-expressing dendritic cells in the rat liver and extrahepatic bile duct. Histochem. Cell Biol. 109:1998;409-415.
54. Maslinski W. Cholinergic receptors of lymphocytes. Brain Behav. Immun. 3:1989;1-14.
55. McCormack R.J., Hart R.P., Ganea D. Expression of NK-1 receptor mRNA in murine T lymphocytes. Neuroimmunomodulation. 3:1996;35-46.
56. Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer P.H., Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:1992;91-98.
57. Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., Satoh S., Niwa M., Senoh H., Fujiwara H. T cell activation-associated hepatic injury: mediation by tumor necrosis factor and protection by interleukin 6. J. Exp. Med. 179:1994;1529-1537.
58. Mizuhara H., Uno M., Seki N., Yamashita M., Yamaoka M., Ogawa T., Kaneda K., Fujii T., Senoh H., Fujiwara H. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestation of hepatitis. Hepatology. 23:1996;1608-1615.
59. Molander C., Ygge J., Dalsgaard C.J. Substance P-, somatostatin- and calcitonin gene-related peptide-like immunoreactivity and fluoride resistant acid phosphatase activity in relation to retrogradely labeled cutaneous, muscular and visceral primary sensory neurons in the rat. Neurosci. Lett. 74:1987;37-42.
60. Moore T.C. Modification of lymphocyte traffic by vasoactive neurotransmitter substances. Immunology. 52:1984;511-518.
61. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65:1983;55-63.
62. Nagaki M., Muto Y., Ohnishi H., Yasuda S., Sano K., Naito T., Maeda T., Yamada T., Moriwaki H. Hepatic injury and lethal shock in galactosamine sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology. 106:1994;450-458.
63. Nair M.P., Schwartz S.A. Substance P induces tumor necrosis factor in an ex vivo model system. Cell Immunol. 166:1995;286-290.
64. 2-Agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100:1997;1513-1519.
65. Payan D.G., Brewster D.R., Goetzl E.J. Specific stimulation of human T lymphocytes by substance P. J. Immunol. 131:1983;1613-1615.
66. Payan D.G., Levine J.D., Goetzl E.J. Modulation of immunity and hypersensitivity by sensory neuropeptides. J. Immunol. 132:1984;1601-1604.
67. Peluso G., Petillo O., Melone M.A., Mazzarella G., Ranieri M., Tajana G.F. Modulation of cytokine production in activated human monocytes by somatostatin. Neuropeptides. 30:1996;443-451.
68. Pochet R., Delespesse G., Gausset P.W., Collet H. Distribution of beta-adrenergic receptors on human lymphocyte subpopulations. Clin. Exp. Immunol. 38:1979;578-584.
69. Rameshwar P., Gascón P., Ganea D. Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins. J. Immunol. 151:1993;2484-2496.
70. Rameshwar P., Gascón P. Hematopoietic modulation by the tachykinins. Acta Haematol. 98:1997;59-64.
71. Reinshagen M., Patel A., Sottili M., French S., Sternini C., Eysselein V.E. Action of sensory neurons in an experimental rat colitis model of injury and repair. Am. J. Physiol. 270:1996;G79-86.
72. Sakuta H., Inaba K., Muramatsu S. Calcitonin gene-related peptide enhances cytokine-induced IL-6 production by fibroblasts. Cell Immunol. 165:1995;20-25.
73. Sanders V.M., Munson A.E. β-adrenoreceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro. J. Pharmacol. Exp. Ther. 230:1984;183-192.
74. Santoni G., Perfumi M., Bressan A.M., Piccoli M. Capsaicin-induced inhibition of mitogen and interleukin-2-stimulated T cell proliferation: reversal by in vivo substance P administration. J. Neuroimmunol. 68:1996;131-138.
75. Schade U.F., Schudt C. The specific type III and Type IV phosphodiesterase inhibitor zardaverine suppressed tumor necrosis factor by macrophages. Eur. J. Pharmacol. 239:1993;9-14.
76. Shadiack A.M., Hart R.P., Carlson C.D., Jonakait G.M. Interleukin-1 induces substance P in sympathetic ganglia through the induction of leukemia inhibitory factor (LIF). J. Neurosci. 13:1993;2601-2609.
77. Sibinga N.E.S., Goldstein A. Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol. 6:1988;219-249.
78. Smith C.H., Barker J.N.W.N., Morris R.W., Mac Donald D.M., Lee T.H. Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J. Immunol. 151:1993;3274-3282.
79. Solorzano C.C., Ksontini R., Pruitt J.H., Hess P.J., Edwards P.D., Kaibara A., Abouhamze A., Auffenberg T., Galardy R.E., Vauthey J.N., Copeland E.M. III, Edwards C.K. III, Lauwers G.Y., Clare-Salzler M., MacKay S.L.D., Moldawer L.L., Lazarus D.D. Involvement of 26-kDa cell-associated TNFα in experimental hepatitis and exacerbation of liver injury with matrix metalloprotease inhibitor. J. Immunol. 158:1997;414-419.
80. Spengler R.N., Allen R.M., Remick D.G., Strieter R.M., Kunkel S.L. Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 145:1990;1430-1434.
81. Stanisz A.M., Befus D., Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from peyer's patches, mesenteric lymph nodes, and spleen. J. Immunol. 136:1986;152-156.
82. Stanisz A.M., Scicchitano R., Dazin P., Bienenstock J., Payan D.G. Distribution of substance P receptors on murine spleen and peyer's patch T and B cells. J. Immunol. 139:1987;749-754.
83. Stevens-Felten S.Y., Bellinger D.L. Noradrenergic and peptidergic innervation of lymphoid organs. Chem. Immunol. 69:1997;99-131.
84. Straub R.H., Herrmann M., Berkmiller G., Frauenholz T., Lang B., Schölmerich J., Falk W. Neuronal regulation of interleukin 6 secretion in murine spleen: adrenergic and opioidergic control. J. Neurochem. 68:1997;1633-1639.
85. Tang H., Sun L., Xin Z., Ganea D. Down-regulation of cytokine expression in murine lymphocytes by PACAP and VIP. Ann. NY Acad. Sci. 805:1996;768-778.
86. Tiegs G., Hentschel J., Wendel A. A T-cell dependent experimental liver injury in mouse inducible by concanavalin A. J. Clin. Invest. 90:1992;196-203.
87. Tiegs, G., Küsters, S., Künstle, G., 1997. T cell-mediated experimental liver injury. In: Berg, P., Lohse, A.W., Tiegs, G., Wendel, A. (Eds.), Autoimmune Liver Disease. Kluwer Academic Publishers, Lancaster, England, pp. 32-42.
88. Tsao C.W., Cheng J.T., Shen C.L., Lin Y.S. 6-Hydroxydopamine induces thymocyte apoptosis in mice. J. Neuroimmunol. 65:1996;91-95.
89. Vishwanath R., Mukherjee R. Substance P promotes lymphocyte-endothelial cell adhesion preferentially via LFA-1/ICAM-1 interactions. J. Neuroimmunol. 71:1996;163-171.
90. Volpes R., vandenOort J., Desmet V.J. Memory T cells represent the predominant lymphocyte subset in acute and chronic liver inflammation. Hepatology. 13:1991;826-829.
91. Watkins L.R., Maier S.F., Goehler L.E. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 63:1995;289-302.
92. Wiegman K., Muthyala S., Kim D.H., Arnason B.G., Chelmicka-Schorr E. Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J. Neuroimmunol. 56:1995;201-206.
93. Willenborg D.O., Fordham S., Bernard C.C., Cowden W.B., Ramshaw I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:1996;3223-3227.
94. Zabel P., Schade U., Schlaak M. Inhibition of endogenous TNF-α formation by pentoxyfylline. Immunobiology. 187:1993;447-463.
95. Zhou Z.Z., Jones S.B. Involvement of central vs. peripheral mechanisms in mediating sympathoadrenal activation in endotoxic rats. Am. J. Physiol. 265:1993;R683-688.